"We felt that an authoritative, practical algorithm for managing type 2 diabetes was essential," former AACE President and Co-Chair of the Algorithm Task Force, Dr. Paul S. Jellinger said. "We believe that this algorithm represents the treatment preferences of most clinical endocrinologists. This is a point-of-care tool that helps clinicians make appropriate and safe treatment decisions."

The algorithm also prioritizes medication choices according to risk of hypoglycemia, safety, efficacy, simplicity and anticipated degree of patient adherence. It was created by a consensus group of leading endocrinologists combining very extensive clinical experience, clinical researchers, practitioners and academicians, and is based on the AACE/ACE Diabetes Guidelines and recent medical literature.

With nearly 80 million people suffering from diabetes and pre-diabetes in the United States, there is a shortage of endocrinologists to care for all patients. Many patients are treated by primary care physicians. The Algorithm represents an important tool to assist and educate clinicians.

SOURCE American Association of Clinical Endocrinologists